Dynatronics Corporation (DYNT)
USD 0.11
(1.92%)
USD 0.11
(1.92%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 9.9 Million USD | -33.96% |
| 2023 | 15 Million USD | -2.77% |
| 2022 | 15.43 Million USD | -7.31% |
| 2021 | 16.64 Million USD | -7.99% |
| 2020 | 18.09 Million USD | -9.41% |
| 2019 | 19.97 Million USD | -7.85% |
| 2018 | 21.67 Million USD | 64.39% |
| 2017 | 13.18 Million USD | 9.41% |
| 2016 | 12.04 Million USD | 18.63% |
| 2015 | 10.15 Million USD | -0.49% |
| 2014 | 10.2 Million USD | -7.06% |
| 2013 | 10.98 Million USD | -7.85% |
| 2012 | 11.91 Million USD | 0.86% |
| 2011 | 11.81 Million USD | 2.24% |
| 2010 | 11.55 Million USD | -1.25% |
| 2009 | 11.7 Million USD | -45.48% |
| 2008 | 21.46 Million USD | 205.12% |
| 2007 | 7.03 Million USD | 0.56% |
| 2006 | 6.99 Million USD | -0.79% |
| 2005 | 7.05 Million USD | 5.63% |
| 2004 | 6.67 Million USD | 11.5% |
| 2003 | 5.98 Million USD | 4.63% |
| 2002 | 5.72 Million USD | -8.08% |
| 2001 | 6.22 Million USD | 8.56% |
| 2000 | 5.73 Million USD | 6.19% |
| 1999 | 5.4 Million USD | 31.71% |
| 1998 | 4.1 Million USD | 2.5% |
| 1997 | 4 Million USD | 37.93% |
| 1996 | 2.9 Million USD | 16.0% |
| 1995 | 2.5 Million USD | -13.79% |
| 1994 | 2.9 Million USD | 7.41% |
| 1993 | 2.7 Million USD | -3.57% |
| 1992 | 2.8 Million USD | 12.0% |
| 1991 | 2.5 Million USD | -7.41% |
| 1990 | 2.7 Million USD | -10.0% |
| 1989 | 3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.54 Million USD | -29.14% |
| 2024 Q3 | 2.38 Million USD | -12.22% |
| 2024 Q4 | 2.25 Million USD | -5.82% |
| 2024 Q2 | 2.72 Million USD | 6.9% |
| 2023 Q1 | 4.11 Million USD | 0.32% |
| 2023 FY | 15 Million USD | -2.77% |
| 2023 Q2 | 3.86 Million USD | -6.22% |
| 2023 Q3 | 3.42 Million USD | -11.21% |
| 2023 Q4 | 3.59 Million USD | 4.78% |
| 2022 FY | 15.43 Million USD | -7.31% |
| 2022 Q1 | 4.09 Million USD | -10.12% |
| 2022 Q2 | 3.48 Million USD | -15.01% |
| 2022 Q3 | 3.74 Million USD | 7.61% |
| 2022 Q4 | 4.1 Million USD | 9.56% |
| 2021 FY | 16.64 Million USD | -7.99% |
| 2021 Q1 | 4.24 Million USD | 16.61% |
| 2021 Q2 | 3.93 Million USD | -7.25% |
| 2021 Q3 | 3.9 Million USD | -0.83% |
| 2021 Q4 | 4.55 Million USD | 16.72% |
| 2020 Q3 | 4.9 Million USD | 6.27% |
| 2020 Q1 | 4.92 Million USD | 0.85% |
| 2020 Q2 | 4.61 Million USD | -6.23% |
| 2020 FY | 18.09 Million USD | -9.41% |
| 2020 Q4 | 3.64 Million USD | -25.81% |
| 2019 Q3 | 4.81 Million USD | 0.95% |
| 2019 Q4 | 4.88 Million USD | 1.35% |
| 2019 FY | 19.97 Million USD | -7.85% |
| 2019 Q1 | 5.49 Million USD | 0.34% |
| 2019 Q2 | 4.77 Million USD | -13.17% |
| 2018 Q3 | 6.45 Million USD | 13.99% |
| 2018 Q4 | 5.47 Million USD | -15.15% |
| 2018 FY | 21.67 Million USD | 64.39% |
| 2018 Q1 | 4.07 Million USD | 13.34% |
| 2018 Q2 | 5.66 Million USD | 38.99% |
| 2017 FY | 13.18 Million USD | 9.41% |
| 2017 Q4 | 3.59 Million USD | 6.24% |
| 2017 Q3 | 3.38 Million USD | 7.06% |
| 2017 Q1 | 3.04 Million USD | -20.64% |
| 2017 Q2 | 3.16 Million USD | 3.86% |
| 2016 FY | 12.04 Million USD | 18.63% |
| 2016 Q4 | 3.83 Million USD | 33.6% |
| 2016 Q3 | 2.87 Million USD | 5.41% |
| 2016 Q2 | 2.72 Million USD | 3.89% |
| 2016 Q1 | 2.62 Million USD | 0.05% |
| 2015 Q3 | 2.45 Million USD | -0.7% |
| 2015 FY | 10.15 Million USD | -0.49% |
| 2015 Q1 | 2.46 Million USD | -1.23% |
| 2015 Q2 | 2.47 Million USD | 0.11% |
| 2015 Q4 | 2.61 Million USD | 6.76% |
| 2014 Q3 | 2.45 Million USD | -3.75% |
| 2014 FY | 10.2 Million USD | -7.06% |
| 2014 Q4 | 2.49 Million USD | 1.66% |
| 2014 Q1 | 2.69 Million USD | -2.43% |
| 2014 Q2 | 2.55 Million USD | -5.2% |
| 2013 FY | 10.98 Million USD | -7.85% |
| 2013 Q4 | 2.76 Million USD | 3.98% |
| 2013 Q3 | 2.65 Million USD | -6.48% |
| 2013 Q2 | 2.83 Million USD | 4.19% |
| 2013 Q1 | 2.72 Million USD | -0.41% |
| 2012 Q3 | 3.02 Million USD | -2.24% |
| 2012 Q4 | 2.73 Million USD | -9.68% |
| 2012 FY | 11.91 Million USD | 0.86% |
| 2012 Q1 | 3.05 Million USD | 1.89% |
| 2012 Q2 | 3.09 Million USD | 1.57% |
| 2011 Q1 | 2.85 Million USD | -0.08% |
| 2011 Q2 | 2.99 Million USD | 4.93% |
| 2011 Q4 | 2.99 Million USD | 0.52% |
| 2011 Q3 | 2.97 Million USD | -0.38% |
| 2011 FY | 11.81 Million USD | 2.24% |
| 2010 Q1 | 2.92 Million USD | 2.13% |
| 2010 Q3 | 2.86 Million USD | -1.26% |
| 2010 Q4 | 2.85 Million USD | -0.59% |
| 2010 Q2 | 2.9 Million USD | -0.75% |
| 2010 FY | 11.55 Million USD | -1.25% |
| 2009 Q3 | 2.5 Million USD | -19.04% |
| 2009 Q1 | 3.23 Million USD | -68.1% |
| 2009 Q2 | 3.09 Million USD | -4.49% |
| 2009 FY | 11.7 Million USD | -45.48% |
| 2009 Q4 | 2.86 Million USD | 14.5% |
| 2008 Q1 | 3.91 Million USD | 101.54% |
| 2008 Q2 | 3.7 Million USD | -5.41% |
| 2008 Q3 | 3.69 Million USD | -0.21% |
| 2008 Q4 | 10.15 Million USD | 174.78% |
| 2008 FY | 21.46 Million USD | 205.12% |
| 2007 FY | 7.03 Million USD | 0.56% |
| 2007 Q3 | 1.69 Million USD | 2.54% |
| 2007 Q1 | 1.73 Million USD | -5.22% |
| 2007 Q2 | 1.65 Million USD | -4.81% |
| 2007 Q4 | 1.94 Million USD | 14.4% |
| 2006 FY | 6.99 Million USD | -0.79% |
| 2006 Q4 | 1.83 Million USD | 5.26% |
| 2006 Q3 | 1.74 Million USD | -0.99% |
| 2006 Q2 | 1.76 Million USD | 6.28% |
| 2006 Q1 | 1.65 Million USD | -9.82% |
| 2005 Q4 | 1.83 Million USD | 6.24% |
| 2005 Q3 | 1.72 Million USD | -0.83% |
| 2005 FY | 7.05 Million USD | 5.63% |
| 2005 Q1 | 1.74 Million USD | 2.95% |
| 2005 Q2 | 1.74 Million USD | 0.15% |
| 2004 Q4 | 1.69 Million USD | -1.83% |
| 2004 Q2 | 1.63 Million USD | 0.16% |
| 2004 Q3 | 1.72 Million USD | 5.56% |
| 2004 FY | 6.67 Million USD | 11.5% |
| 2004 Q1 | 1.62 Million USD | 4.85% |
| 2003 FY | 5.98 Million USD | 4.63% |
| 2003 Q2 | 1.46 Million USD | 1.58% |
| 2003 Q1 | 1.44 Million USD | 6.76% |
| 2003 Q4 | 1.55 Million USD | 2.42% |
| 2003 Q3 | 1.51 Million USD | 3.26% |
| 2002 Q3 | 1.42 Million USD | -1.88% |
| 2002 FY | 5.72 Million USD | -8.08% |
| 2002 Q4 | 1.35 Million USD | -4.75% |
| 2002 Q2 | 1.44 Million USD | -3.02% |
| 2002 Q1 | 1.49 Million USD | -5.39% |
| 2001 Q2 | 1.53 Million USD | 7.86% |
| 2001 Q3 | 1.68 Million USD | 9.58% |
| 2001 Q4 | 1.58 Million USD | -6.17% |
| 2001 FY | 6.22 Million USD | 8.56% |
| 2001 Q1 | 1.42 Million USD | -2.09% |
| 2000 Q2 | 1.3 Million USD | 8.33% |
| 2000 Q3 | 1.72 Million USD | 32.78% |
| 2000 FY | 5.73 Million USD | 6.19% |
| 2000 Q1 | 1.2 Million USD | -7.69% |
| 2000 Q4 | 1.45 Million USD | -15.7% |
| 1999 Q2 | 1.4 Million USD | -6.67% |
| 1999 Q4 | 1.3 Million USD | 8.33% |
| 1999 FY | 5.4 Million USD | 31.71% |
| 1999 Q1 | 1.5 Million USD | 25.0% |
| 1999 Q3 | 1.2 Million USD | -14.29% |
| 1998 Q3 | 1 Million USD | -9.09% |
| 1998 FY | 4.1 Million USD | 2.5% |
| 1998 Q1 | 1 Million USD | -16.67% |
| 1998 Q2 | 1.1 Million USD | 10.0% |
| 1998 Q4 | 1.2 Million USD | 20.0% |
| 1997 Q4 | 1.2 Million USD | 20.0% |
| 1997 Q3 | 1 Million USD | 11.11% |
| 1997 Q1 | 900 Thousand USD | 0.0% |
| 1997 Q2 | 900 Thousand USD | 0.0% |
| 1997 FY | 4 Million USD | 37.93% |
| 1996 FY | 2.9 Million USD | 16.0% |
| 1996 Q4 | 900 Thousand USD | 50.0% |
| 1996 Q3 | 600 Thousand USD | 0.0% |
| 1996 Q2 | 600 Thousand USD | -14.29% |
| 1996 Q1 | 700 Thousand USD | 0.0% |
| 1995 FY | 2.5 Million USD | -13.79% |
| 1995 Q3 | 600 Thousand USD | 0.0% |
| 1995 Q2 | 600 Thousand USD | -14.29% |
| 1995 Q1 | 700 Thousand USD | -12.5% |
| 1995 Q4 | 700 Thousand USD | 16.67% |
| 1994 Q2 | 600 Thousand USD | -33.33% |
| 1994 Q1 | 900 Thousand USD | 28.57% |
| 1994 FY | 2.9 Million USD | 7.41% |
| 1994 Q4 | 800 Thousand USD | 14.29% |
| 1994 Q3 | 700 Thousand USD | 16.67% |
| 1993 Q4 | 700 Thousand USD | 0.0% |
| 1993 Q1 | 600 Thousand USD | -25.0% |
| 1993 FY | 2.7 Million USD | -3.57% |
| 1993 Q2 | 600 Thousand USD | 0.0% |
| 1993 Q3 | 700 Thousand USD | 16.67% |
| 1992 Q3 | 700 Thousand USD | 16.67% |
| 1992 Q2 | 600 Thousand USD | 0.0% |
| 1992 Q1 | 600 Thousand USD | 0.0% |
| 1992 Q4 | 800 Thousand USD | 14.29% |
| 1992 FY | 2.8 Million USD | 12.0% |
| 1991 Q2 | 600 Thousand USD | 0.0% |
| 1991 Q1 | 600 Thousand USD | -25.0% |
| 1991 Q4 | 600 Thousand USD | 0.0% |
| 1991 Q3 | 600 Thousand USD | 0.0% |
| 1991 FY | 2.5 Million USD | -7.41% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | 800 Thousand USD | 14.29% |
| 1990 FY | 2.7 Million USD | -10.0% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q3 | 700 Thousand USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | 3 Million USD | 0.0% |
| 1989 Q4 | -6.4 Million USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 82.488% |
| BrainsWay Ltd. | 28.01 Million USD | 64.637% |
| Cerus Corporation | 143.15 Million USD | 93.079% |
| Envoy Medical, Inc. | 17.89 Million USD | 44.642% |
| electroCore, Inc. | 32.03 Million USD | 69.067% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 20.666% |
| IceCure Medical Ltd | 16.87 Million USD | 41.289% |
| Inogen, Inc. | 236.08 Million USD | 95.803% |
| OrthoPediatrics Corp. | 137.01 Million USD | 92.769% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 76.65% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 43.81% |
| MaxCyte, Inc. | 84.84 Million USD | 88.322% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 20.172% |
| Nexalin Technology, Inc. | 5.78 Million USD | -71.379% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.515% |
| PAVmed Inc | 64.82 Million USD | 84.716% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 80.602% |
| RxSight, Inc. | 103.85 Million USD | 90.459% |
| Sight Sciences, Inc. | 126.44 Million USD | 92.164% |
| SI-BONE, Inc. | 156.35 Million USD | 93.663% |
| TELA Bio, Inc. | 84.18 Million USD | 88.231% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 95.128% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 60.282% |
| Acutus Medical, Inc. | 11.22 Million USD | 11.725% |
| Talis Biomedical Corporation | 67.18 Million USD | 85.253% |
| Spectral AI, Inc. | 20.86 Million USD | 52.511% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 82.306% |
| CVRx, Inc. | 76.14 Million USD | 86.987% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -180.84% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 12.788% |
| Bioventus Inc. | 409.91 Million USD | 97.583% |
| Venus Concept Inc. | 80.47 Million USD | 87.688% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 85.857% |
| LivaNova PLC | 843.54 Million USD | 98.825% |
| 908 Devices Inc. | 68.08 Million USD | 85.446% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.951% |
| Nemaura Medical Inc. | 7.13 Million USD | -38.791% |
| NeuroPace, Inc. | 75.29 Million USD | 86.841% |
| LENSAR, Inc. | 33.33 Million USD | 70.278% |
| Apyx Medical Corporation | 51.01 Million USD | 80.579% |
| Cutera, Inc. | 197.72 Million USD | 94.989% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 60.018% |
| BioSig Technologies, Inc. | 28.53 Million USD | 65.272% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 94.825% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 72.523% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.815% |
| Axonics, Inc. | 270.2 Million USD | 96.333% |
| Outset Medical, Inc. | 198.77 Million USD | 95.015% |
| IRIDEX Corporation | 31.81 Million USD | 68.856% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 94.502% |
| IRadimed Corporation | 30.12 Million USD | 67.108% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -16.128% |
| INVO Bioscience, Inc. | 7.85 Million USD | -26.164% |
| Telesis Bio, Inc. | 63.48 Million USD | 84.394% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 89.936% |
| Varex Imaging Corporation | 224.8 Million USD | 95.593% |
| Quipt Home Medical Corp. | 148.66 Million USD | 93.335% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 15.482% |
| Pulmonx Corporation | 112.68 Million USD | 91.207% |
| Modular Medical, Inc. | 17.52 Million USD | 43.476% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 50.919% |
| Semler Scientific, Inc. | 38.94 Million USD | 74.558% |
| InMode Ltd. | 215.68 Million USD | 95.406% |
| Bruker Corporation | 1.07 Billion USD | 99.08% |
| Cytosorbents Corporation | 48.33 Million USD | 79.502% |
| DexCom, Inc. | 1.69 Billion USD | 99.414% |
| Align Technology, Inc. | 2.07 Billion USD | 99.523% |
| Viveve Medical, Inc. | 22.17 Million USD | 55.315% |
| ZimVie Inc. | 275.12 Million USD | 96.399% |
| Movano Inc. | 29.69 Million USD | 66.628% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 92.782% |
| Nexalin Technology, Inc. | 5.78 Million USD | -71.379% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -180.84% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.351% |
| Profound Medical Corp. | 33.6 Million USD | 70.515% |
| Insulet Corporation | 939.9 Million USD | 98.946% |
| enVVeno Medical Corporation | 25.23 Million USD | 60.742% |
| Surmodics, Inc. | 98.69 Million USD | 89.961% |
| iCAD, Inc. | 22.22 Million USD | 55.419% |
| Nuwellis, Inc. | 22.61 Million USD | 56.184% |
| Biotricity, Inc. | 17.18 Million USD | 42.343% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.778% |
| Aethlon Medical, Inc. | 12.27 Million USD | 19.299% |
| InspireMD, Inc. | 22.95 Million USD | 56.828% |
| PAVmed Inc. | 64.82 Million USD | 84.716% |
| BIOLASE, Inc. | 34.66 Million USD | 71.414% |
| Beyond Air, Inc. | 61.7 Million USD | 83.942% |
| FONAR Corporation | 28.6 Million USD | 65.362% |
| AxoGen, Inc. | 149.33 Million USD | 93.365% |
| Vivani Medical, Inc. | 26.96 Million USD | 63.256% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 94.405% |
| Inari Medical, Inc. | 448.59 Million USD | 97.791% |
| UFP Technologies, Inc. | 58.08 Million USD | 82.943% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -101.072% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -56.815% |
| Tenon Medical, Inc. | 16.96 Million USD | 41.608% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -34.019% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 77.534% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.081% |
| Sintx Technologies, Inc. | 15.2 Million USD | 34.82% |
| NanoVibronix, Inc. | 4.97 Million USD | -99.236% |
| Quanterix Corporation | 118.1 Million USD | 91.61% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 15.482% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 31.394% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.477% |
| TransMedics Group, Inc. | 182.82 Million USD | 94.58% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 64.696% |
| NeuroMetrix, Inc. | 11.09 Million USD | 10.73% |
| Hyperfine, Inc. | 52.87 Million USD | 81.26% |
| Establishment Labs Holdings Inc. | 172 Million USD | 94.24% |
| Biomerica, Inc. | 6.97 Million USD | -41.989% |
| Bone Biologics Corporation | 9.42 Million USD | -5.088% |
| AVITA Medical, Inc. | 80.77 Million USD | 87.734% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 3.91% |
| Silk Road Medical, Inc | 186.35 Million USD | 94.683% |